Replies to post #63117 on Progressive Care Inc (RXMD)

[ndww42]

That’s not what Armen said. Re read the post. Armen thinks the valuation of the company is 1-2 times sales.

Stock price is not 1:1 with valuation because this is the OTC.

I also think 1-2 times sales for the company valuation is fair. That equates to 20-40 million.

Once they have their second location the multiples begin to expand.

They’re not Fortune 500 yet so it’s a very conservative approach.

As for the stock price, Armen has stated many times he thinks it should be around 50 cents+.